IN191203B - - Google Patents

Info

Publication number
IN191203B
IN191203B IN263DE1999A IN191203B IN 191203 B IN191203 B IN 191203B IN 263DE1999 A IN263DE1999 A IN 263DE1999A IN 191203 B IN191203 B IN 191203B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Amarnath Prof Maitra
Sanjeev Kumar Dr Sahoo
Prasanta Kumar Ghosh
Original Assignee
Amarnath Prof Maitra
Sanjeev Kumar Dr Sahoo
Prasanta Kumar Ghosh
Dabur Res Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amarnath Prof Maitra, Sanjeev Kumar Dr Sahoo, Prasanta Kumar Ghosh, Dabur Res Foundation filed Critical Amarnath Prof Maitra
Priority to IN263DE1999 priority Critical patent/IN191203B/en
Priority to US09/401,927 priority patent/US6322817B1/en
Priority to US09/667,417 priority patent/US6365191B1/en
Publication of IN191203B publication Critical patent/IN191203B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IN263DE1999 1999-02-17 1999-02-17 IN191203B (cg-RX-API-DMAC10.html)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IN263DE1999 IN191203B (cg-RX-API-DMAC10.html) 1999-02-17 1999-02-17
US09/401,927 US6322817B1 (en) 1999-02-17 1999-09-23 Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof
US09/667,417 US6365191B1 (en) 1999-02-17 2000-09-21 Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN263DE1999 IN191203B (cg-RX-API-DMAC10.html) 1999-02-17 1999-02-17

Publications (1)

Publication Number Publication Date
IN191203B true IN191203B (cg-RX-API-DMAC10.html) 2003-10-04

Family

ID=11088992

Family Applications (1)

Application Number Title Priority Date Filing Date
IN263DE1999 IN191203B (cg-RX-API-DMAC10.html) 1999-02-17 1999-02-17

Country Status (2)

Country Link
US (1) US6322817B1 (cg-RX-API-DMAC10.html)
IN (1) IN191203B (cg-RX-API-DMAC10.html)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1286643A2 (en) * 2000-05-17 2003-03-05 Labopharm Inc. Drug containing polymeric micelles
DE10108710B4 (de) * 2001-02-23 2011-01-20 Umarex Sportwaffen Gmbh & Co Kg Handfeuerwaffe
US20030157161A1 (en) * 2001-05-01 2003-08-21 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating inflammatory conditions utilizing protein or polysaccharide containing anti-microtubule agents
WO2002087563A2 (en) * 2001-05-01 2002-11-07 Angiotech Pharmaceuticals Inc. Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
US6939564B2 (en) * 2001-06-08 2005-09-06 Labopharm, Inc. Water-soluble stabilized self-assembled polyelectrolytes
US6780324B2 (en) * 2002-03-18 2004-08-24 Labopharm, Inc. Preparation of sterile stabilized nanodispersions
CN1761485B (zh) * 2003-03-20 2010-04-28 日本化药株式会社 含略微水溶性抗癌剂和新型嵌段共聚物的胶束制剂
ES2226567B1 (es) * 2003-06-20 2006-07-01 Universidad De Santiago De Compostela Nanoparticulas de acido hialuronico.
ES2232287B1 (es) * 2003-07-04 2006-11-01 Advanced In Vitro Cell Technologies, S.L. Nanoparticulas de derivados polioxietilenados.
ES2246694B1 (es) * 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Nanoparticulas pegiladas.
ES2246695B1 (es) * 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
WO2006010083A2 (en) * 2004-07-08 2006-01-26 Molecular Therapeutics, Inc. Biodegradable nanoparticles
KR100578382B1 (ko) * 2004-07-16 2006-05-11 나재운 항암제의 전달체용 수용성 키토산 나노입자 및 그 제조방법
US8119153B2 (en) * 2004-08-26 2012-02-21 Boston Scientific Scimed, Inc. Stents with drug eluting coatings
US20070281007A1 (en) * 2004-08-27 2007-12-06 Jacob Jules S Mucoadhesive Oral Formulations of High Permeability, High Solubility Drugs
WO2006026592A2 (en) * 2004-08-27 2006-03-09 Spherics, Inc. Oral administration of poorly absorbed drugs, methods and compositions related thereto
US8945629B2 (en) * 2004-09-10 2015-02-03 University Of Wyoming Nanoparticles for cytoplasmic drug delivery to cancer cells
WO2006033296A1 (ja) * 2004-09-22 2006-03-30 Nippon Kayaku Kabushiki Kaisha 新規ブロック共重合体、ミセル調製物及びそれを有効成分とする抗癌剤
US7727554B2 (en) * 2004-12-21 2010-06-01 Board Of Regents Of The University Of Nebraska By And Behalf Of The University Of Nebraska Medical Center Sustained-release nanoparticle compositions and methods for using the same
JP5116108B2 (ja) * 2005-09-09 2013-01-09 トクレ チョン， 抗癌剤の伝達体用水溶性キトサンナノ粒子及びその製造方法
US20070104753A1 (en) * 2005-11-04 2007-05-10 Aiden Flanagan Medical device with a coating comprising an active form and an inactive form of therapeutic agent(s)
AU2006329554C1 (en) * 2005-12-28 2013-06-20 Fresenius Kabi Oncology Limited A biocompatible, non-biodegradable, non-toxic polymer useful for nanoparticle pharmaceutical compositions
KR20080106254A (ko) 2006-03-28 2008-12-04 니폰 가야꾸 가부시끼가이샤 탁산류의 고분자 결합체
EP2019122A4 (en) 2006-05-18 2009-07-01 Nippon Kayaku Kk POLYMER CONJUGATE OF PODOPHYL LOTOXIN
WO2008004988A1 (en) * 2006-07-06 2008-01-10 Agency For Science, Technology And Research Thermally responsive micelles
JP2010504318A (ja) * 2006-09-22 2010-02-12 ラボファーム インコーポレイテッド ｐＨ標的化薬剤送達のための組成物及び方法
EP2070971B1 (en) * 2006-10-03 2016-06-22 Nippon Kayaku Kabushiki Kaisha Compound of resorcinol derivative with polymer
MX2009003680A (es) * 2006-10-05 2009-07-17 Univ Johns Hopkins Formulaciones orales, parenterales y topicas dispersables en agua para farmacos deficientemente solubles en agua con el uso de nanoparticulas polimericas inteligentes.
EP2080779B1 (en) 2006-11-06 2016-05-18 Nippon Kayaku Kabushiki Kaisha Polymeric derivative of nucleic acid metabolic antagonist
US8188222B2 (en) 2006-11-08 2012-05-29 Nippon Kayaku Kabushiki Kaisha High molecular weight derivative of nucleic acid antimetabolite
US20090036625A1 (en) * 2007-08-01 2009-02-05 Chung Yuan Christian University Amphiphilic Polymer, Method for Forming the Same and Application thereof
EP2206502B1 (en) * 2007-09-28 2018-09-12 Nippon Kayaku Kabushiki Kaisha Polymer conjugate of steroid
KR101478779B1 (ko) * 2007-11-22 2015-01-05 에스케이케미칼주식회사 재수화시간이 향상된 택산 유도체 함유 동결건조 조성물 및이의 제조방법
KR101502533B1 (ko) * 2007-11-22 2015-03-13 에스케이케미칼주식회사 우수한 안정성을 갖는 택산 유도체 함유 주사제용동결건조 조성물 및 이의 제조방법
CN103190396A (zh) * 2008-02-21 2013-07-10 巴斯夫欧洲公司 涂覆的惰性颗粒
EP2258397B1 (en) * 2008-03-18 2017-10-11 Nippon Kayaku Kabushiki Kaisha Polymer conjugate of physiologically active substance
ES2358493B1 (es) * 2008-04-05 2012-06-13 Instituto Cientifico Y Tecnologico De Navarra, S.A Nanopartículas pegiladas que comprenden una molécula biológicamente activa y sus aplicaciones.
US9149540B2 (en) 2008-05-08 2015-10-06 Nippon Kayaku Kabushiki Kaisha Polymer conjugate of folic acid or folic acid derivative
WO2010131675A1 (ja) 2009-05-15 2010-11-18 日本化薬株式会社 水酸基を有する生理活性物質の高分子結合体
CA2816997A1 (en) 2010-11-17 2012-05-24 Nippon Kayaku Kabushiki Kaisha Novel polymer derivative of cytidine metabolic antagonist
CN103874722B (zh) 2011-09-11 2016-06-29 日本化药株式会社 嵌段共聚物的制造方法
US20140010760A1 (en) * 2012-04-05 2014-01-09 Brij P. Giri Hypoxia-Targeted Polymeric Micelles For Cancer Therapy And Imaging
EP2777694A1 (en) 2013-03-14 2014-09-17 Brij P. Giri Hypoxia-Targeted Polymeric Micelles for Cancer Therapy and Imaging
CN104434876B (zh) * 2013-09-13 2018-04-27 布里吉·P·吉里 用于癌症疗法及成像的缺氧-标靶聚合微胞
WO2015136477A1 (en) * 2014-03-12 2015-09-17 Murli Krishna Pharma Pvt. Ltd. Nanoparticles of polymer and lipid mixture core for targeted drug delivery
RU2018113280A (ru) 2015-09-16 2019-10-16 ДиЭфБи СОРИА, ЭлЭлСи Доставка наночастиц лекарственного средства и способы их использования
US10792477B2 (en) 2016-02-08 2020-10-06 Orbusneich Medical Pte. Ltd. Drug eluting balloon
EP3426352A4 (en) 2016-03-08 2019-11-13 Los Gatos Pharmaceuticals, Inc. CAMPTOTHECIN DERIVATIVES AND USES THEREOF
US10064855B2 (en) 2016-03-08 2018-09-04 Los Gatos Pharmaceuticals, Inc. Composite nanoparticles and uses thereof
KR102658256B1 (ko) 2017-03-15 2024-04-16 디에프비 소리아, 엘엘씨 탁산 나노입자를 사용한 피부 악성 종양의 치료용 국소 요법
JP7372252B2 (ja) 2018-03-16 2023-10-31 ディーエフビー ソリア リミテッド ライアビリティ カンパニー タキサンのナノ粒子を用いる子宮頸部上皮内腫瘍（ｃｉｎ）および子宮頸癌の処置のための局所療法
RU2752314C1 (ru) * 2020-07-10 2021-07-26 Общество с ограниченной ответственностью "Таргет-Инжиниринг" Способ получения наноразмерных систем олигопептид-полимерная частица на основе амфифильных сополимеров N-винилпирролидона с (ди)метакрилатами и их применение в качестве активного вещества в косметологии и медицине

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3922193A (en) 1992-03-23 1993-10-21 Georgetown University Liposome encapsulated taxol and a method of using the same
WO1993024476A1 (en) * 1992-06-04 1993-12-09 Clover Consolidated, Limited Water-soluble polymeric carriers for drug delivery
US5684169A (en) 1992-11-27 1997-11-04 Ensuiko Sugar Refining Co., Ltd. Cyclodextrin inclusion complex of taxol, and method for its production and its use

Also Published As

Publication number Publication date
US6322817B1 (en) 2001-11-27

Similar Documents

Publication Publication Date Title
BE2018C020I2 (cg-RX-API-DMAC10.html)
BE2015C057I2 (cg-RX-API-DMAC10.html)
BE2016C007I2 (cg-RX-API-DMAC10.html)
BE2015C018I2 (cg-RX-API-DMAC10.html)
BE2014C017I2 (cg-RX-API-DMAC10.html)
BE2013C051I2 (cg-RX-API-DMAC10.html)
BE2013C020I2 (cg-RX-API-DMAC10.html)
BE2013C015I2 (cg-RX-API-DMAC10.html)
BE2013C001I2 (cg-RX-API-DMAC10.html)
BE2012C036I2 (cg-RX-API-DMAC10.html)
FR10C0006I1 (cg-RX-API-DMAC10.html)
JP2002503528A5 (cg-RX-API-DMAC10.html)
JP2002525908A5 (cg-RX-API-DMAC10.html)
BRPI0017527B8 (cg-RX-API-DMAC10.html)
IN191203B (cg-RX-API-DMAC10.html)
BRPI0001542A2 (cg-RX-API-DMAC10.html)
JP2002509243A5 (cg-RX-API-DMAC10.html)
JP2002517298A5 (cg-RX-API-DMAC10.html)
JP2002531867A5 (cg-RX-API-DMAC10.html)
BRPI0017522A2 (cg-RX-API-DMAC10.html)
JP2002524384A5 (cg-RX-API-DMAC10.html)
JP2002520150A5 (cg-RX-API-DMAC10.html)
JP2002515636A5 (cg-RX-API-DMAC10.html)
BRMU7902607U2 (cg-RX-API-DMAC10.html)
BRPI0303609A (cg-RX-API-DMAC10.html)